<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<doc>
  <docno>
    <textblock>FR940216-2-00023</textblock>
  </docno>
  <parent>
    <textblock>FR940216-2-00013</textblock>
  </parent>
  <text/>
  <usbureau>
    <textblock>Food and Drug Administration</textblock>
  </usbureau>
  <doctitle>
    <textblock>Consumer Participation; Notice of Open Meeting</textblock>
  </doctitle>
  <agency>
    <textblock>AGENCY:</textblock>
    <textblock>Food and Drug Administration, HHS.</textblock>
  </agency>
  <action>
    <textblock>ACTION:</textblock>
    <textblock>Notice.</textblock>
  </action>
  <summary>
    <textblock>SUMMARY:</textblock>
    <textblock>The Food and Drug Administration (FDA) is announcing the following district consumer exchange meeting: Detroit, Michigan District Office, chaired by Carl Reynolds, District Director. The topics to be discussed are medical devices, current good manufacturing practice regulations, proposed revisions, and request for comments.</textblock>
  </summary>
  <date>
    <textblock>DATES:</textblock>
    <textblock>Thursday, February 24, 1994, 1 p.m. to 3 p.m.</textblock>
  </date>
  <address>
    <textblock>ADDRESSES:</textblock>
    <textblock>Methodist Hospital Auditorium, 1601 North Senate Ave., Indianapolis, IN 46206.</textblock>
  </address>
  <further>
    <textblock>FOR FURTHER INFORMATION CONTACT:</textblock>
    <textblock>Janet LeClair, Public Affairs Specialist, Food and Drug Administration, 101 West Ohio St., Indianapolis, IN 46204, 317-226-6500.</textblock>
  </further>
  <supplem>
    <textblock>SUPPLEMENTARY INFORMATION:</textblock>
    <textblock>The purpose of this meeting is to encourage dialogue between consumers and FDA officials, to identify and set priorities for current and future health concerns, to enhance relationships between local consumers and FDA's district offices, and to contribute to the agency's policymaking decisions on vital issues.</textblock>
    <textblock>Dated: February 9, 1994.</textblock>
  </supplem>
  <signer>
    <textblock>Michael R. Taylor,</textblock>
  </signer>
  <signjob>
    <textblock>Deputy Commissioner for Policy.</textblock>
  </signjob>
  <frfiling>
    <textblock>[FR Doc. 94-3571 Filed 2-15-94; 8:45 am]</textblock>
  </frfiling>
  <billing>
    <textblock>BILLING CODE 4160-01-F</textblock>
  </billing>
</doc>
